Any
organism whose genetic material has been modified using genetic
engineering technique in laboratory is referred as genetically
modified organism (GMO). Genetic modification of genetic material is
practiced for production of specific biological product or for
expression of specific physiological traits in an organism.
Genetically modified organisms are produced using reproductive
cloning and recombinant deoxyribonucleic acid (DNA) technology.
Transfer of entire donor nucleus into enucleated cytoplasm of host
egg result in an offspring which is identical to its parent.
Reproductive cloning generates offspring. While on the other hand,
recombinant deoxyribonucleic acid (DNA) technology involves insertion
of multiple genes from an individual of one species into
deoxyribonucleic acid (DNA) of another species. The first animal
produced using reproductive cloning technique was a sheep named Dolly
in 1996. Since then, many animals such as pigs, dogs and horses, have
been generated using reproductive cloning technique.
Request
to view Sample Report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=6565
Based
on the species of an organism, the global genetically modifies
organisms market has been segmented as follows:
Genetically
modified organisms market involves ethical issues and thus, the
market is highly regulated in majority of the countries globally. For
instance, labeling of genetically modified food has become a topic of
controversy in the U.S. in recent times. In addition, high risk of
genetic pollution is another issue surrounding genetically modified
food. Thus, ethical issues involved in the production are primarily
restraining the growth of global genetically modified organisms
market.
Geographically,
the global genetically modified organisms (GMO) market has been
segmented into North America, Europe, Asia Pacific and Rest of the
World (RoW). North America comprises genetically modified organisms
(GMO) market for the U.S and Canada. Europe comprises cumulative
market of genetically modified organisms (GMO) in Germany, Italy,
France, Spain, and Rest of Europe (RoE). Asia Pacific comprises
cumulative market of genetically modified organisms (GMO) in China,
India, Australia, New Zealand and rest of Asia Pacific (RoAPAC). Rest
of the World (RoW) comprises genetically modified organisms (GMO)
market in Latin America, Middle East and Russia. Presently, North
America and Europe dominates the global genetically modified
organisms market. Factors such as highly developed research
infrastructure, well defined regulatory framework, availability of
skilled scientists and exceptionally developed biotechnology sector
are driving the growth of the genetically modified organisms (GMO)
market in North America and Europe. Asia Pacific genetically modified
organism (GMO) market is anticipated to grow at the highest CAGR
during the forecast period from 2014 to 2020. Governments of
countries such as India and China are investing heavily on
biotechnology sector to boost the biotechnology industry in
respective countries. In addition, India and China account for the
largest population pool in the world leading to increase food in
consumption needs. Rising food consumption is anticipated to drive
the demand for genetically modified organism market in these
countries. Ministry of Agriculture regulates the genetically modified
organisms (GMO) market in China. Argentina, Brazil, Mexico, and South
Africa, are some of the countries in the rest of the world (RoW)
region that are expected to show higher growth in the near future.
No comments:
Post a Comment